of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On July 23, 2026 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the…

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On April 30, 2026 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of th…

Executive Vice President and Chief Information Officer — Paola Arbour: Ms. Arbour is retiring from her executive role but will remain employed in a non-executive capacity for transition support.

Senior Vice President & Controller (Principal Accounting Officer) — R. Scott Ramsey: Mr. Ramsey is retiring and will be succeeded by J. Michael Grooms.

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On February 11, 2026 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of…

Results of Operations and Financial Condition. On February 2, 2026, Tenet Healthcare Corporation (the “Company”) issued a press release announcing the Company’s expectation that its Adjusted EBITDA for the year ended December 31, 2025 will be at the upper end of its current Adjusted EBITDA guidance range of $4.47 billion to $4.57 billion. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. The Company’s actual results for the year ended…

Director — Stephen H. Rusckowski: A director resigned from the board, reducing the board size, which is a standard governance change rather than a loss of a C-suite executive.

Entry into a Material Definitive Agreement. The information set forth below in

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On November 18, 2025, Tenet Healthcare Corporation (“Tenet”) issued $1,500,000,000 in aggregate principal amount of 5.500% senior secured first lien notes due 2032 (the “First Lien Notes”) and $750,000,000 in aggregate principal amount of 6.000% senior notes due 2033 (the “Senior Notes” and together with the First Lien Notes, the “Notes”). The First Lien Notes were issued pursuan…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth above in

Entry into a Material Definitive Agreement. New Credit Agreement On November 4, 2025 (the “Closing Date”), Tenet Healthcare Corporation, a Nevada corporation (“Tenet”), entered into a Credit Agreement (the “ABL Agreement”) to provide for a senior secured revolving credit facility (the “Facility”), by and among Tenet, as the borrower, the lenders and issuers party thereto and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “ABL Agent”). The ABL Agreement has an effect…

Regulation FD Disclosure. On November 3, 2025 , Tenet Healthcare Corporation (the “Company”) issued a press release announcing the commencement of private placement offerings of $1.5 billion in aggregate principal amount of its senior secured first lien notes due 2032 and $0.50 billion in aggregate principal amount of its senior notes due 2033. A copy of the press release is furnished as Exhibit 99.1 attached hereto and is incorporated herein by reference. Additionally, on November 3, 2025 ,…

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On October 28, 2025 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of…

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On July 22, 2025 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the…

COO — Lisa Y. Foo: The filing discloses the promotion of an existing executive to a newly created Chief Operating Officer role, which is an internal advancement rather than a departure.

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On April 29, 2025 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of th…

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On February 12, 2025 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of…

CEO — Saumya Sutaria, M.D.: The filing discloses an amended and restated employment agreement for the sitting CEO, which is a compensatory arrangement rather than a change in management personnel.

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On October 29, 2024 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of…

Other Events. On August 5, 2024, the Company and certain of its subsidiaries announced entering into a definitive agreement (the “Sale Agreement”) for the sale of our 70% ownership interest in five hospitals located in Alabama (Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Walker Baptist Medical Center, Princeton Baptist Medical Center and Shelby Baptist Medical Center) and certain related operations to Orlando Health (“Purchaser”). Subject to the terms and conditions in…

Regulation FD Disclosure. On August 5, 2024, the Company issued a press release announcing the anticipated sale of our 70% ownership interest in five hospitals located in Alabama (Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Walker Baptist Medical Center, Princeton Baptist Medical Center and Shelby Baptist Medical Center) and certain related operations (the “Divested Facilities”) for approximately $910 million in cash (after-tax proceeds of approximately $790 million). A…

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On July 24, 2024 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the…

of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On April 30, 2024 , Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of th…